Login
Products
Login
Home
Alerts
Search
Watchlist
Products

NACL Industries Ltd

NACLIND
NSE
159.41
1.59%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

NACL Industries Ltd

NACLIND
NSE
159.41
1.59%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
3,733Cr
Close
Close Price
159.41
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
PS
Price To Sales
2.62
Revenue
Revenue
1,425Cr
Rev Gr TTM
Revenue Growth TTM
-4.38%
PAT Gr TTM
PAT Growth TTM
-12.85%
Peer Comparison
How does NACLIND stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
NACLIND
VS

Quarterly Results

Upcoming Results on
4 May 2026
Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
599376580365457325440268201448457318
Growth YoY
Revenue Growth YoY%
27.1-20.92.7-23.9-23.6-13.5-24.1-26.7-55.938.03.818.8
Expenses
ExpensesCr
531404550361446329400294275410412312
Operating Profit
Operating ProfitCr
67-2931411-441-26-7438457
OPM
OPM%
11.3-7.65.31.12.4-1.19.3-9.8-36.78.59.82.1
Other Income
Other IncomeCr
43114242301-170
Interest Expense
Interest ExpenseCr
171820191918171514141312
Depreciation
DepreciationCr
977777778788
PBT
PBTCr
46-516-20-11-2720-47-66186-14
Tax
TaxCr
13-122-4-2-65-10-1654-3
PAT
PATCr
34-384-16-9-2115-36-50133-10
Growth YoY
PAT Growth YoY%
64.5-355.1-86.3-196.2-126.945.4265.2-127.9-454.9162.7-82.972.0
NPM
NPM%
5.6-10.10.7-4.3-2.0-6.43.4-13.5-24.82.90.6-3.2
EPS
EPS
1.6-1.80.2-0.7-0.4-0.90.7-1.7-2.30.60.1-0.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
7466927358478651,0151,1911,6332,1161,7791,2351,425
Growth
Revenue Growth%
17.3-7.26.215.22.217.317.437.129.5-15.9-30.615.4
Expenses
ExpensesCr
7026366797988529461,0791,4931,9231,7621,2971,409
Operating Profit
Operating ProfitCr
44565649146911314119317-6316
OPM
OPM%
5.98.17.65.71.66.89.58.69.11.0-5.11.1
Other Income
Other IncomeCr
26194120278151111103814
Interest Expense
Interest ExpenseCr
353738333429282747766553
Depreciation
DepreciationCr
252728202024252528272931
PBT
PBTCr
10113115-132475100128-76-119-55
Tax
TaxCr
32-14-77242634-17-27-10
PAT
PATCr
893212-717517395-59-92-45
Growth
PAT Growth%
135.816.1258.5-63.4-160.1340.9204.644.029.2-162.1-56.451.6
NPM
NPM%
1.01.34.31.4-0.81.64.34.54.5-3.3-7.5-3.1
EPS
EPS
0.50.61.90.7-0.40.92.43.44.4-2.7-4.2-2.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
161616161719202020202020
Reserves
ReservesCr
162170213223247338397469554491407424
Current Liabilities
Current LiabilitiesCr
4413563684324315534538311,1151,143727947
Non Current Liabilities
Non Current LiabilitiesCr
47695342274410419622616410996
Total Liabilities
Total LiabilitiesCr
6656116517137429559761,5161,9151,8181,2631,487
Current Assets
Current AssetsCr
4544164625305556916931,1301,4121,288706967
Non Current Assets
Non Current AssetsCr
211195189183188264283385504530557521
Total Assets
Total AssetsCr
6656116517137429559761,5161,9151,8181,2631,487

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
404658243610383-124-2050469
Investing Cash Flow
Investing Cash FlowCr
-18-12-6-14-27-9714-163-142-384
Financing Cash Flow
Financing Cash FlowCr
-27-33-58-11-970-113290135-22-448
Net Cash Flow
Net Cash FlowCr
-41-5-1077-162-28-925
Free Cash Flow
Free Cash FlowCr
243463253710383-124-2011438
CFO To PAT
CFO To PAT%
530.6517.4184.8211.6-523.9615.5163.5-169.3-21.5-85.6-509.0
CFO To EBITDA
CFO To EBITDA%
91.681.6104.450.4264.8150.274.0-88.3-10.6296.1-746.0

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2133094386175014307461,6111,6271,1262,048
Price To Earnings
Price To Earnings
26.831.913.453.40.025.614.622.017.10.00.0
Price To Sales
Price To Sales
0.30.50.60.70.60.40.61.00.80.61.7
Price To Book
Price To Book
1.21.71.92.61.91.21.83.32.82.24.8
EV To EBITDA
EV To EBITDA
9.09.111.217.049.98.37.714.511.8108.6-38.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.836.738.233.629.429.729.925.824.522.226.1
OPM
OPM%
5.98.17.65.71.66.89.58.69.11.0-5.1
NPM
NPM%
1.01.34.31.4-0.81.64.34.54.5-3.3-7.5
ROCE
ROCE%
12.111.916.010.74.48.716.612.413.50.0-6.6
ROE
ROE%
4.34.813.84.8-2.64.712.215.016.5-11.5-21.6
ROA
ROA%
1.11.44.91.6-0.91.85.24.85.0-3.2-7.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** NACL Industries Limited is an established, integrated agrochemical company founded in **1993** in India. The company specializes in the end-to-end development, manufacturing, and marketing of **crop protection chemicals**, including technical-grade active ingredients (AIs), intermediates, and proprietary formulated products such as insecticides, herbicides, fungicides, and plant growth regulators (PGRs). It operates across three key segments: **Domestic Retail, Institutional (B2B), and Exports**. In **August 2025**, a pivotal ownership change occurred when **Coromandel International Limited**, a leading agri-solutions provider and part of the prestigious **Murugappa Group (revenue: ₹778 billion)**, acquired majority control of NACL Industries. This strategic acquisition marks a new phase of growth, operational revival, and value creation for NACL. --- ### **Business Segments & Market Presence** - **Domestic Retail**: NACL serves over **5 million Indian farmers** through a **direct-to-retail distribution model**, supported by **47 stock points** and **over 12,500 retail outlets** nationwide. - Offers **66+ branded agrochemical formulations**, with strong market presence in rice, cotton, pulses, oilseeds, and vegetables. - Key recent launches include **Rozzer (Topramezone SC)** and **Temboguard (Tembotrione SC)** for maize, **Bushi (mite control)**, and **Suraksha SC (lepidopteran pests)**. - Farmers are engaged through **knowledge delivery programs**, field demonstrations, and the **Krishi Kalyan App**, which provides diagnostics, treatment guidance, and usage data. - **Export & B2B (Toll Manufacturing)**: - Exports to **22 countries**, including developed markets like the **USA, Japan, and Australia**, and emerging markets in Asia, Africa, Latin America, and the Middle East. - Historically, exports accounted for up to **35% of revenue** (FY23), with strong relationships with global MNCs such as **Syngenta, Nissan Chemical, and Saraswati Agro Chemicals**. - Acts as a **reliable contract manufacturer**, supplying active ingredients and intermediates under long-term partnerships. - Export segment has shown robust growth, including a **250% volume increase (FY24)** in formulations to Asia and Africa. --- ### **Manufacturing & Capacity** NACL operates a vertically integrated manufacturing framework with four production units located across **Andhra Pradesh** and **Gujarat**: - **Srikakulam (AP)**: AI manufacturing (upgraded to 70.1 TPD from 30 TPD); ZLD-compliant. - **Ethakota (AP)**: Formulation and packaging facility. - **Dahej (Gujarat)**: Fully operational **6,000 TPA** plant via **NACL Spec-Chem Limited (NSCL)**. - Future **greenfield site near Visakhapatnam** for fluorinated chemicals is in development. #### **Current Production Capacities**: | Segment | Capacity (Annual) | |--------|-------------------| | Technical Manufacturing | 17,000 TPA (post-consolidation) | | Formulation Handling | 12,000 KL (liquids), 5,600 MT (powders), **35,000 MT (granules)** | | Formulation & Packaging | Up to 53,000 MT/KL combined (Ethakota plant) | - Capacity utilization currently at **~70%**, with ongoing **de-bottlenecking and expansion projects** to support scale-up. - Strategic investments aim to expand into **specialty chemicals and advanced intermediates**. --- ### **Research & Development** NACL’s **R&D Center**, located on a **4-acre campus in Shadnagar, Hyderabad**, is a cornerstone of innovation: - Employs **~70 scientists** focused on: - Development of complex chemistries, generic AIs, combination formulations. - **Fluorination technology** – a **pioneering capability** in India at pilot and lab scale. - Process optimization, impurity profiling, method validation, and stability studies. - **Accreditations**: - **GLP-certified** (OECD-compliant), accepted in USA, EU, Japan, and other OECD countries. - **ISO 17025:2017** and **DSIR-recognized**. - **Recent Milestones (Aug 2025)**: - Developed processes for **4 technical products** (2 commercialized, 2 at pilot stage). - Commercialized **5 new formulations**, including **Speed (Imidacloprid + Fipronil WG)** and **Carpet (Pyroxasulfone WG)**. - Filed **2 provisional patents**; over **20 patent applications** filed (Jan 2024). - Successfully executed **commercial-scale intermediate supply for multinational clients**. --- ### **Subsidiaries & Group Structure** NACL has a diversified corporate structure with **6 subsidiaries** and 1 associate: - **NACL Spec-Chem Limited (NSCL)** – Dahej, Gujarat (6,000 TPA AI/intermediates; Rs 300+ crore FY24 revenue). - **NACL Agri-Solutions Private Limited (NASPL)** – Launched innovative liquid nutrients (Zinc Oxide SC, Boron Ethanolamine). Reported **₹71 lakhs revenue** in FY25 (from ₹2 lakhs). - **NACL Multichem Private Limited** – Greenfield facility in Srikakulam (38,000 MTPA planned). - **Nagarjuna Agrichem (Australia) Pty Limited** - **NACL Industries (Nigeria) Limited** – Incorporated Jan 2023; no capital transferred as of March 2025. - **LR Research Laboratories Private Limited** **Associate**: Nasense Labs Private Limited. Following Coromandel's acquisition, NACL operates under the broader **Murugappa Group**, which includes **Coromandel International, Cholamandalam, CUMI, and CG Power**. --- ### **Strategic Developments & Initiatives** - **Acquisition Strategy**: Plans to **acquire a controlling stake in a target crop protection company** to build synergies in manufacturing, product portfolio, and market reach. - **Farmer-Centric Innovation**: R&D and product development driven by field feedback, digital tools, and AI-based customer engagement. - **Sustainability & Digital Transformation**: - Embracing **responsible manufacturing, automation, and Zero Liquid Discharge (ZLD)**. - Launching **biocontrol solutions, liquid nutrient formulations, and digital advisory platforms**. - Participating in India’s **“Make in India”** mission by developing import-substitute intermediates. - **Expansion Targets**: - Entering **new geographies** and strengthening presence in Africa (Nigeria subsidiary), Southeast Asia, and Latin America. - Scaling **product registrations** – over 100 dossiers submitted in 2024. - Expanding **greenfield sites in Dahej and Srikakulam**. --- ### **Financial & Operational Performance** - **FY23 Revenue**: ₹**2,116 crores** (+29% YoY), driven by export growth (+40%), retail expansion (+25%). - **FY24–25 Challenges**: - Impacted by **erratic monsoons**, **working capital constraints**, **raw material volatility**, and **global softness in technical demand**. - Temporary lender restrictions affected procurement and order fulfillment in H2 FY25. - **Revival Strategy**: - Completed **capital-intensive revival** with change in promoter group (Coromandel takeover). - Improved access to credit, operational expertise, and governance.